Get the Stockscreener App
0.148
7.25%
0.010
After Hours:
.14
-0.008
-5.41%
Accelerate Diagnostics Inc stock is traded at $0.148, with a volume of 3.93M.
It is up +7.25% in the last 24 hours and down -75.21% over the past month.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
See More
Previous Close:
$0.138
Open:
$0.13
24h Volume:
3.93M
Relative Volume:
17.66
Market Cap:
$13.40M
Revenue:
$12.00M
Net Income/Loss:
$-63.23M
P/E Ratio:
-0.0247
EPS:
-6
Net Cash Flow:
$-43.02M
1W Performance:
-72.08%
1M Performance:
-75.21%
6M Performance:
-91.91%
1Y Performance:
-82.99%
1-Day Range:
$0.125
$0.164
1-Week Range:
$0.117
$0.5599
52-Week Range:
$0.117
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Name
Accelerate Diagnostics Inc
Sector
Industry
Phone
303-863-8088
Address
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Compare AXDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.148 | 13.40M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-22 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-08-20 | Initiated | BTIG Research | Neutral |
| Aug-07-20 | Upgrade | Craig Hallum | Hold → Buy |
| Sep-27-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| May-24-18 | Initiated | Craig Hallum | Hold |
| Dec-13-17 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-12-17 | Resumed | BTIG Research | Buy |
| Mar-24-16 | Initiated | JP Morgan | Overweight |
| Dec-16-15 | Initiated | Piper Jaffray | Overweight |
View All
Accelerate Diagnostics Inc Stock (AXDX) Latest News
Accelerate Diagnostics files for Chapter 11 bankruptcy, seeks asset sale amid financial strain - The Business Journals
Post-Trade Analysis: Accelerate Diagnostics Inc (AXDX) Slides -70.39, Closing at 0.14 - DWinneX
Accelerate Diagnostics initiates Chapter 11 and asset sale By Investing.com - Investing.com Nigeria
Accelerate Diagnostics Files for Chapter 11 Bankruptcy - TipRanks
Accelerate Diagnostics files for Chapter 11 - USA Herald
Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan - Law360
Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets - marketscreener.com
Accelerate Diagnostics (AXDX) Starts Chapter 11 for Asset Sale | - GuruFocus
Accelerate Diagnostics Initiates Chapter 11 Restructuring Proceeding - Nasdaq
Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - Stock Titan
Accelerate Diagnostics files for Chapter 11 bankruptcy - marketscreener.com
Motion for Joint Administration Filed by Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics, Inc. Filed for Bankruptcy - marketscreener.com
Renaissance Technologies LLC Grows Position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Raymond James Has Negative Forecast for TSE:BEI Q1 Earnings - The AM Reporter
Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics grants CEO retention bonus - Investing.com Australia
Accelerate Diagnostics grants CEO retention bonus By Investing.com - Investing.com Canada
Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Decrease in Short Interest - Defense World
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - The Manila Times
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire
Accelerate Diagnostics adds new independent directors - Investing.com Australia
Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada
Accelerate Diagnostics (AXDX) Appoints New Directors and Forms S - GuruFocus
Accelerate Diagnostics Appoints New Independent Directors - TipRanks
Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance
Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com UK
Accelerate Diagnostics CTO sells shares worth $989 - Investing.com
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com
Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView
AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance
Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com
Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa
Accelerate Diagnostics CFO sells shares worth $4,839 - Investing.com
Accelerate Diagnostics (NASDAQ:AXDX) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World
AXDX stock touches 52-week low at $0.73 amid market challenges By Investing.com - Investing.com South Africa
AXDX stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia
Accelerate Diagnostics Inc Stock (AXDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):